Aboard Air Force One (AFP) | 15/05/2026 - 13:11:51 | Trump says Xi 'feels strongly' Iran can't have nuclear weapon ...
FT2109 is an investigational oral TNF signaling inhibitor (TNFsi) designed to selectively target soluble TNF while sparing membrane TNF signaling, with the goal of improving safety and therapeutic ...
Intrathecal baclofen (ITB) therapy is an established treatment for severe refractory spasticity. Although a positive ITB ...
FDA expands Vyvgart and Vyvgart Hytrulo approval for generalized myasthenia gravis to include all adult patients regardless of antibody serotype.
Annexon (NASDAQ:ANNX) President and CEO Doug Love outlined the company's late-stage pipeline and regulatory plans during a ...
Increasing bone density in patients with a rare genetic condition that causes bones to break easily does not prevent ...
Rare neuromuscular diseases often lack treatments because developing targeted drugs is slow, costly and risky for companies.
Genetically modified nematodes provide a new disease model to screen potential treatments for a rare neurogenetic disorder ...
A new study suggests that certain genetic diseases may be treatable with carefully matched vitamins, including a deadly ...
Osteoarthritis, far from being “simply wear and tear,” demands a multifaceted management strategy, according to a speaker at ...
Monoclonal antibodies can block a key immune‑related protein that drives the spread of brain cell damage in Parkinson's ...
Bank of America Global Healthcare Conference 2026 May 13, 2026 2:20 PM EDTCompany ParticipantsDouglas Love - CEO, President ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results